Stock listing
ASX:RGT Argent Biopharma Ltd Share Price
Home listing (ASX) of Argent Biopharma Ltd
Follow Argent Biopharma Ltd into a list and get an email when it puts out news.
Share price · ASX:RGT
$0.025 AUD 0.000 (0.0%)
Close on Nov 2, 2026
- Day range
- $0.024 – $0.025 AUDNov 2, 2026
- Volume
- 41,134 sharesNov 2, 2026
- Market cap
- $2.95M AUDAt the close on Nov 2, 2026 · price × 117.9M shares outstanding
- 52-week range
- $0.023 – $0.110 AUDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $6,186 AUDMedian day 62,158 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| ASX:RGT · Home | $0.025 AUD | 0.000 (0.0%) | 41,134 | $0.024 | $0.025 | $0.024 | $0.025 | Close on Nov 2, 2026 |
| Frankfurt:H5O0 | €0.011 EUR | 0.000 (0.0%) | — | €0.011 | €0.011 | €0.011 | €0.011 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · ASX:RGT · AUD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.025 | 0.000 | 0.0% | $0.024 | $0.025 | $0.024 | 41,134 | |
| $0.025 | +0.001 | +4.2% | $0.024 | $0.025 | $0.023 | 144,259 | |
| $0.024 | -0.003 | -11.1% | $0.024 | $0.024 | $0.024 | 15,001 | |
| $0.027 | +0.002 | +8.0% | $0.025 | $0.027 | $0.025 | 20,000 | |
| $0.025 | -0.004 | -13.8% | $0.025 | $0.025 | $0.024 | 163,223 | |
| $0.029 | -0.003 | -9.4% | $0.027 | $0.029 | $0.027 | 31,250 | |
| $0.032 | -0.002 | -5.9% | $0.032 | $0.032 | $0.032 | 24,141 | |
| $0.034 | +0.007 | +25.9% | $0.024 | $0.034 | $0.024 | 76,446 | |
| $0.027 | 0.000 | 0.0% | $0.027 | $0.027 | $0.027 | 16,811 | |
| $0.027 | -0.001 | -3.6% | $0.027 | $0.027 | $0.027 | 15,022 | |
| $0.028 | +0.001 | +3.7% | $0.027 | $0.028 | $0.027 | 19,000 | |
| $0.027 | 0.000 | 0.0% | $0.027 | $0.027 | $0.027 | 15,000 | |
| $0.027 | +0.001 | +3.8% | $0.027 | $0.027 | $0.025 | 304,625 | |
| $0.026 | -0.002 | -7.1% | $0.027 | $0.028 | $0.026 | 36,379 | |
| $0.028 | -0.002 | -6.7% | $0.030 | $0.030 | $0.028 | 120,487 | |
| $0.030 | -0.001 | -3.2% | $0.031 | $0.031 | $0.030 | 72,805 | |
| $0.031 | -0.002 | -6.1% | $0.031 | $0.031 | $0.030 | 41,293 | |
| $0.033 | -0.001 | -2.9% | $0.030 | $0.033 | $0.030 | 27,973 | |
| $0.034 | +0.006 | +21.4% | $0.029 | $0.034 | $0.029 | 35,000 | |
| $0.028 | -0.002 | -6.7% | $0.030 | $0.030 | $0.028 | 168,685 | |
| $0.030 | -0.002 | -6.3% | $0.030 | $0.030 | $0.030 | 10,000 | |
| $0.032 | +0.002 | +6.7% | $0.030 | $0.032 | $0.030 | 60,000 | |
| $0.030 | 0.000 | 0.0% | $0.030 | $0.033 | $0.030 | 64,316 | |
| $0.030 | -0.002 | -6.3% | $0.036 | $0.040 | $0.030 | 1,205,180 | |
| $0.032 | 0.000 | 0.0% | $0.032 | $0.033 | $0.032 | 15,035 | |
| $0.032 | -0.001 | -3.0% | $0.032 | $0.032 | $0.032 | 7,000 | |
| $0.033 | +0.002 | +6.5% | $0.031 | $0.033 | $0.031 | 35,897 | |
| $0.031 | 0.000 | 0.0% | $0.033 | $0.033 | $0.031 | 11,230 | |
| $0.031 | 0.000 | 0.0% | $0.031 | $0.031 | $0.031 | 7,692 | |
| $0.031 | 0.000 | 0.0% | $0.031 | $0.031 | $0.031 | 7,000 | |
| $0.031 | 0.000 | 0.0% | $0.031 | $0.031 | $0.031 | 1,057 | |
| $0.031 | 0.000 | 0.0% | $0.031 | $0.031 | $0.030 | 104,973 | |
| $0.031 | 0.000 | 0.0% | $0.031 | $0.032 | $0.031 | 90,747 | |
| $0.031 | -0.002 | -6.1% | $0.031 | $0.031 | $0.031 | 56,898 | |
| $0.033 | +0.002 | +6.5% | $0.031 | $0.033 | $0.031 | 20,416 | |
| $0.031 | -0.001 | -3.1% | $0.032 | $0.034 | $0.031 | 139,768 | |
| $0.032 | 0.000 | 0.0% | $0.032 | $0.034 | $0.032 | 13,006 | |
| $0.032 | 0.000 | 0.0% | $0.032 | $0.032 | $0.032 | 13 | |
| $0.032 | 0.000 | 0.0% | $0.032 | $0.032 | $0.032 | 13,816 | |
| $0.032 | +0.002 | +6.7% | $0.031 | $0.032 | $0.031 | 48,465 | |
| $0.030 | -0.001 | -3.2% | $0.032 | $0.034 | $0.030 | 225,250 | |
| $0.031 | -0.002 | -6.1% | $0.033 | $0.033 | $0.030 | 15,573 | |
| $0.033 | 0.000 | 0.0% | $0.033 | $0.034 | $0.032 | 199,401 | |
| $0.033 | +0.001 | +3.1% | $0.032 | $0.033 | $0.031 | 306,086 | |
| $0.032 | -0.002 | -5.9% | $0.035 | $0.035 | $0.032 | 598,008 | |
| $0.034 | -0.003 | -8.1% | $0.037 | $0.037 | $0.034 | 337,885 | |
| $0.037 | -0.002 | -5.1% | $0.039 | $0.039 | $0.037 | 127,558 | |
| $0.039 | +0.002 | +5.4% | $0.038 | $0.039 | $0.035 | 302,961 | |
| $0.037 | -0.001 | -2.6% | $0.039 | $0.039 | $0.037 | 66,964 | |
| $0.038 | -0.001 | -2.6% | $0.038 | $0.040 | $0.037 | 257,884 | |
| $0.039 | +0.001 | +2.6% | $0.038 | $0.039 | $0.038 | 1,266 | |
| $0.038 | -0.001 | -2.6% | $0.040 | $0.040 | $0.036 | 512,355 | |
| $0.039 | 0.000 | 0.0% | $0.037 | $0.039 | $0.037 | 125,079 | |
| $0.039 | -0.001 | -2.5% | $0.038 | $0.040 | $0.036 | 842,338 | |
| $0.040 | +0.002 | +5.3% | $0.040 | $0.041 | $0.038 | 33,533 | |
| $0.038 | -0.002 | -5.0% | $0.040 | $0.040 | $0.038 | 143,989 | |
| $0.040 | +0.002 | +5.3% | $0.038 | $0.040 | $0.038 | 248,223 | |
| $0.038 | -0.003 | -7.3% | $0.039 | $0.040 | $0.038 | 349,979 | |
| $0.041 | +0.002 | +5.1% | $0.039 | $0.041 | $0.039 | 16,857 | |
| $0.039 | -0.001 | -2.5% | $0.040 | $0.040 | $0.038 | 400,274 | |
| $0.040 | -0.005 | -11.1% | $0.045 | $0.047 | $0.040 | 672,439 | |
| $0.045 | +0.007 | +18.4% | $0.038 | $0.045 | $0.037 | 1,310,904 | |
| $0.038 | 0.000 | 0.0% | $0.038 | $0.039 | $0.036 | 128,941 | |
| $0.038 | -0.002 | -5.0% | $0.040 | $0.042 | $0.036 | 561,800 |
- Ticker
- ASX:RGT
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- ASX
- Currency
- AUD
What changed lately
Latest news release · Oct 26, 2026
RGT Executes Global Licence for Non-Core Cannabis Genetics
Latest news
RGT Executes Global Licence for Non-Core Cannabis Genetics
Oct 26, 2026
Closed $0.025 (-13.8%) on Oct 27, 2026
Quarterly Activities/Appendix 4C Cash Flow Report
Oct 22, 2026
Closed $0.032 (-5.9%) on Oct 23, 2026
Execution of Loan Facility Agreement
Sep 30, 2026
Closed $0.032 (+6.7%) on Oct 1, 2026
Argent Signs NLC Licence to Expand Antiviral Portfolio
Sep 28, 2026
Closed $0.03 (-6.3%) on Sep 29, 2026
Appendix 4E and 2026 Annual Report
Aug 31, 2026
Closed $0.033 (0.0%) on Sep 1, 2026
FDA-CVM Establish INAD File for CannEpil Veterinary Program
Aug 25, 2026
Closed $0.037 (-5.1%) on Aug 26, 2026
US Veterinary Development Programme for CannEpil Commences
Aug 5, 2026
Closed $0.04 (-11.1%) on Aug 6, 2026
CannEpil Global Licence Expands into Veterinary Healthcare
Jul 30, 2026
Closed $0.04 (+8.1%) on Jul 31, 2026
RGT Executes Global CannEpil Licensing Deal for US$5.5M
Jul 6, 2026
Closed $0.072 (+105.7%) on Jul 7, 2026
Half Yearly Report and Accounts
Feb 27, 2026
Closed $0.05 (-10.7%) on Mar 2, 2026
Decks
Investor Presentation (June 2025)
Investor deck · 25 slides · Jun 10, 2025
Investor Presentation (September 2024)
Investor deck · 26 slides · Sep 6, 2024
Investor Presentation (June 2024)
Investor deck · 15 slides · Jul 1, 2024
Investor Presentation (April 2021)
Investor deck · 25 slides · Apr 9, 2021
Argent Biopharma Ltd on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 15 in the last 12 months · 302 in all · newest Oct 26, 2026 · oldest 2016
- Decks
- 7 decks · latest Jun 10, 2025
Where Argent Biopharma Ltd is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| ASX:RGT · Home listing · This page | ASX | Australia | AUD |
| OTC:RGTLF | OTC | United States | USD |
| Lang & Schwarz:A40A1Q | Lang & Schwarz | Germany | EUR |
| LS Exchange:A2ACB6 | LS Exchange | Germany | EUR |
| LS Exchange:A40A1Q | LS Exchange | Germany | EUR |
| gettex:H5O0 | gettex | Germany | EUR |
| Dusseldorf:H5O0 | Dusseldorf | Germany | EUR |
| Frankfurt:H5O0 | Frankfurt | Germany | EUR |
| Lang & Schwarz:A2ACB6 | Lang & Schwarz | Germany | EUR |
| Stuttgart:H5O0 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Argent Biopharma Ltd.